Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HR091506 / Jiangsu Hengrui Pharma
NCT06139393: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults	Not yet recruiting	3	750	NA	HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets	Jiangsu HengRui Medicine Co., Ltd.	Gout With Hyperuricemia in Adults	11/24	06/25
NCT06414837: Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults	Not yet recruiting	3	434	NA	HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets	Jiangsu HengRui Medicine Co., Ltd.	Gout With Hyperuricemia in Adults	06/26	06/26
NCT05347498: A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults	Not yet recruiting	1	90	NA	HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets	Jiangsu HengRui Medicine Co., Ltd.	Primary Gout With Hyperuricemia in Adults	07/22	07/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HR091506 / Jiangsu Hengrui Pharma
NCT06139393: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults	Not yet recruiting	3	750	NA	HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets	Jiangsu HengRui Medicine Co., Ltd.	Gout With Hyperuricemia in Adults	11/24	06/25
NCT06414837: Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults	Not yet recruiting	3	434	NA	HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets	Jiangsu HengRui Medicine Co., Ltd.	Gout With Hyperuricemia in Adults	06/26	06/26
NCT05347498: A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults	Not yet recruiting	1	90	NA	HR091506 tablets + placebo of febuxostat tablets, febuxostat tablets + placebo of HR091506 tablets	Jiangsu HengRui Medicine Co., Ltd.	Primary Gout With Hyperuricemia in Adults	07/22	07/22